Why surgery is not always possible — and what is done instead

“Inoperable.” “Unresectable.” “Not a surgical candidate.” These phrases get used loosely, and they land hard. In pancreatic cancer they almost always mean one specific thing: on the scans in front of the team today, an operation could not remove the whole tumour with a clear margin — or an operation would not help, because disease has already been found somewhere else. That is a technical judgement about anatomy and spread. It is not a judgement about whether you will be treated.

The question people ask us first is why is pancreatic cancer inoperable so much more often than other cancers. The answer is anatomy. The pancreas sits in the deepest part of the upper abdomen, draped across the major blood vessels that feed the intestines, the liver and the spleen. A tumour has to grow only a short distance in the wrong direction before it is touching an artery that cannot be taken out with it. Add a disease that spreads early and quietly, often before it causes a single symptom, and a large share of tumours are already past the point of clean removal on the day they are found.

There is a second reason, and it has nothing to do with the tumour at all. Pancreatic surgery is a long operation that rebuilds part of the digestive tract. Someone whose heart, lungs, liver function, weight or general strength would not carry them through it is not offered it, even when the tumour itself looks removable. That is a judgement about the person rather than the cancer — and unlike the vessels, it is one that can sometimes be changed with drainage of the jaundice, enzymes, nutrition and a few weeks of rebuilding.

What follows from either answer is the part that matters. Chemotherapy, radiation, relief of a blocked bile duct, proper pain control, enzyme and nutrition support all continue, and for one group of people the operability question is genuinely asked again a few months later with a different answer. Locally advanced pancreatic cancer — can it become operable? follows that possibility through in full.

1. 1

   The category is confirmed, not assumed

   Your imaging is reviewed at a tumour board with medical, radiation and surgical oncology in the room. Where the existing scan cannot answer the vessel question properly, a dedicated pancreatic-protocol CT is repeated before anyone accepts the word inoperable.

   In-house at CION
2. 2

   Systemic treatment starts

   Combination chemotherapy is the backbone, and for most people it is the first and most important thing that happens. It treats the whole body, and the response to it also tells the team how this particular cancer behaves. Chemotherapy for advanced pancreatic cancer explains what it is aiming at and how progress is judged.

   In-house at CION
3. 3

   Jaundice and blockage are relieved

   Where the bile duct is obstructed, a stent is placed endoscopically so the jaundice settles, the itching stops and chemotherapy can be given safely. Where the duodenum is narrowed, the same approach can restore eating. Both are arranged and scheduled by us and performed at a partner unit.

   Coordinated with gastroenterology and endoscopy partners
4. 4

   Pain is treated as a priority, not an afterthought

   Pancreatic pain that bores into the back responds to a stepped medication plan, and where medication alone is not enough, a coeliac plexus block can interrupt the nerve signal directly. The block is done by partner specialists; the pain, palliative and psycho-oncology care around it is ours.

   Block coordinated with partners; supportive care in-house
5. 5

   Nutrition and enzymes are sorted early

   Most people with a pancreatic tumour are not absorbing food properly, and losing weight makes every treatment harder to tolerate. Pancreatic enzyme replacement with meals, a dietitian review and attention to blood sugar are started at the beginning, not after the weight has already gone.

   In-house at CION
6. 6

   Reimaging, and the question is asked again

   After a period of systemic treatment, the scans and the CA 19-9 trend are reviewed together. If nothing has spread and the tumour has pulled back from the vessels, local treatment such as chemoradiation or focused radiation may follow, and the operability question goes back to the partner surgical team for a fresh answer.

   In-house at CION, with coordinated surgical review

An inoperable assessment deserves to be understood, and sometimes deserves to be checked. Not because doctors are usually wrong — they usually are not — but because the word covers several very different situations, and because the imaging it rests on has to be the right kind. A general abdominal scan is not the same as a dedicated pancreatic-protocol study with the arterial and venous phases timed properly, and the vessel question cannot be answered reliably without one.

Be careful with what you read afterwards. Published outlook figures for pancreatic cancer are historical, they average across categories that behave nothing like each other, and many of them fold in pancreatic neuroendocrine tumours, which follow a far better course than the common form of the disease. A number built from that mixture describes a group of people from years ago. It does not describe you, your scan or your response to treatment, and we will not quote one at you to sound authoritative.

What a first visit gives you is a free 45-minute consultation, long enough for a medical oncologist to read the actual images with you rather than the summary line, name the category, name the reason, and say what would have to change for the answer about surgery to be different. If the honest answer is that it is not going to change, you will be told that too, along with what treatment is aiming at instead.

• Which category am I in, and which vessel is the problem? Ask for the artery or vein by name. “Inoperable” on its own is not an answer you can plan around.
• Is it the tumour, the spread, or my fitness that is stopping surgery? These three have very different chances of changing, and only the first two are about the cancer.
• Was the scan a dedicated pancreatic-protocol study? If it was not, ask whether repeating it properly could change the assessment.
• What would have to happen for the operability question to be reopened? There should be a specific answer: a scan at a stated point, a marker trend, a response.
• What is being done about jaundice, pain, appetite and weight, starting this week? None of these should wait for the cancer plan to be finalised.
• Which parts are billed by CION and which by a partner hospital? Ask for the split in writing, and about Aarogyasri, NTR Vaidya Seva or your own insurance for each part.

Medical disclaimer: This page explains what an inoperable or unresectable assessment means in pancreatic cancer, what decides it and what treatment follows, and is reviewed by a CION medical oncologist with reference to NCCN guidance on pancreatic adenocarcinoma. It is general information and not a substitute for an individual opinion; resectability depends on your own imaging, pathology and general condition and must be decided with your treating team. Chemotherapy and maintenance treatment, radiation, chemoradiation and SBRT, tumour-board review and the resectability discussion, pancreatic-protocol CT, MRI/MRCP, CA 19-9 and bloods, genetic counselling, nutrition and pancreatic enzyme (PERT) support, pain relief, psycho-oncology and survivorship follow-up are delivered by CION. All pancreatic surgery, staging laparoscopy, endoscopic ultrasound and biopsy, ERCP and biliary or duodenal stenting, coeliac plexus block, PET-CT and DOTATATE PET and PRRT are coordinated with specialist hepatobiliary, gastroenterology, endoscopy and nuclear medicine partner centres and may be billed there.